• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Quantum-Si And 2 Other Penny Stocks Insiders Are Buying

    3/7/24 6:33:14 AM ET
    $LAB
    $QSI
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Machinery/Components
    Industrials
    Get the next $LAB alert in real time by email

    The Dow Jones index closed higher by around 75 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

    Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

    Earth Science Tech

    • The Trade: Earth Science Tech, Inc. (OTC:ETST) Director Yovan Arturo Sanchez acquired a total of 100,000 shares an average price of $0.08. To acquire these shares, it cost around $7,500.
    • What’s Happening: On Jan. 29, Earth Science Tech announced a $5 million common stock repurchase program.
    • What Earth Science Tech Does: Earth Science Tech Inc is a diversified holding company. Currently, the company is focused on emerging prospects in the health and wellness industry.

    Standard BioTools

    • The Trade: Standard BioTools Inc. (NASDAQ:LAB) Director Eli Casdin acquired a total of 251,403 shares at at an average price of $2.57. To acquire these shares, it cost around $646,169.
    • What’s Happening: On Feb. 28, the company reported better-than-expected fourth-quarter revenue results.
    • What Standard BioTools Does: Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster.

    Check This Out: Top 3 Defensive Stocks That May Explode This Month

    Quantum-Si

    • The Trade: Quantum-Si incorporated (NASDAQ:QSI) CFO Jeffry R. Keyes acquired a total of 50,000 shares at an average price of $1.61. The insider spent around $80,500 to buy those shares.
    • What’s Happening: On Feb. 29, Quantum-Si posted upbeat quarterly results.
    • What Quantum-Si Does: Quantum-Si Inc is focused on revolutionizing the growing field of proteomics.

     

    Don’t forget to check out our premarket coverage here

    Get the next $LAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAB
    $QSI

    CompanyDatePrice TargetRatingAnalyst
    Standard BioTools Inc.
    $LAB
    8/13/2025$1.55Buy → Hold
    TD Cowen
    Standard BioTools Inc.
    $LAB
    2/27/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Quantum-Si Incorporated
    $QSI
    2/7/2025$3.75Buy
    Alliance Global Partners
    Standard BioTools Inc.
    $LAB
    4/16/2024$3.50Buy
    TD Cowen
    Standard BioTools Inc.
    $LAB
    4/4/2024$3.25Buy
    Jefferies
    Quantum-Si Incorporated
    $QSI
    12/8/2023$3.00Buy
    H.C. Wainwright
    Quantum-Si Incorporated
    $QSI
    9/25/2023$3.50 → $2.00Buy → Hold
    Canaccord Genuity
    Standard BioTools Inc.
    $LAB
    7/12/2023$4.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $LAB
    $QSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Standard BioTools downgraded by TD Cowen with a new price target

    TD Cowen downgraded Standard BioTools from Buy to Hold and set a new price target of $1.55

    8/13/25 8:03:50 AM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Standard BioTools downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Standard BioTools from Overweight to Sector Weight

    2/27/25 6:22:46 AM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Alliance Global Partners initiated coverage on Quantum-Si with a new price target

    Alliance Global Partners initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.75

    2/7/25 8:29:38 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $LAB
    $QSI
    SEC Filings

    View All

    Amendment: Standard BioTools Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K/A - STANDARD BIOTOOLS INC. (0001162194) (Filer)

    2/5/26 4:38:13 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Standard BioTools Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - STANDARD BIOTOOLS INC. (0001162194) (Filer)

    1/30/26 9:18:32 AM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Standard BioTools Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - STANDARD BIOTOOLS INC. (0001162194) (Filer)

    1/8/26 7:10:25 AM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $LAB
    $QSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Product Officer Vieceli John S. sold $27,979 worth of shares (21,927 units at $1.28), decreasing direct ownership by 3% to 800,973 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    12/22/25 8:11:48 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    GC & Corp. Secretary Lapointe Christian sold $15,249 worth of shares (11,951 units at $1.28), decreasing direct ownership by 1% to 948,855 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    12/22/25 8:01:22 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Keyes Jeffry R. sold $11,008 worth of shares (8,627 units at $1.28), decreasing direct ownership by 0.74% to 1,163,197 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    12/22/25 7:50:21 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $LAB
    $QSI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $LAB
    $QSI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si's Board of Directors has granted 52,296 restricted stock units ("RSUs") to new employees under the Company's previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the "2023 Inducement Plan"). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4). The 2023 Inducement Plan is used exclusively for the grant of equity awards

    2/13/26 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternat

    2/10/26 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

    BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ:LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, after U.S. market close. About Standard BioTools Inc. Standard BioTools Inc. (NASDAQ:LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcome

    2/10/26 7:00:00 AM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Casdin Partners Master Fund, L.P. bought $502,570 worth of shares (350,000 units at $1.44) (SEC Form 4)

    4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)

    12/4/25 8:59:44 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Casdin Partners Master Fund, L.P. bought $10,053,280 worth of shares (7,700,000 units at $1.31) (SEC Form 4)

    4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)

    11/26/25 4:58:37 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Casdin Partners Master Fund, L.P. bought $1,374,575 worth of shares (1,075,000 units at $1.28) (SEC Form 4)

    4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)

    11/20/25 7:45:54 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $LAB
    $QSI
    Financials

    Live finance-specific insights

    View All

    Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternat

    2/10/26 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Reports Third Quarter 2025 Financial Results

    Announces Successful Sequencing on Prototype Proteus Unit, Development Program Remains On-Track Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the third quarter ended September 30, 2025. Press Release Highlights Reported revenue of $552,000 for the third quarter of 2025 Announced successful sequencing runs on a prototype Proteus system. The development program remains on track. Highlighted early success with instrument placement program, providing increased access to academic customers Highlighted recent launch and

    11/5/25 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the third quarter 2025 on Wednesday, November 5, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, ind

    10/13/25 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $LAB
    $QSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Standard BioTools Inc.

    SC 13G/A - STANDARD BIOTOOLS INC. (0001162194) (Subject)

    11/14/24 3:32:10 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Standard BioTools Inc.

    SC 13G/A - STANDARD BIOTOOLS INC. (0001162194) (Subject)

    11/12/24 6:01:47 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Standard BioTools Inc.

    SC 13G/A - STANDARD BIOTOOLS INC. (0001162194) (Subject)

    11/4/24 1:59:57 PM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $LAB
    $QSI
    Leadership Updates

    Live Leadership Updates

    View All

    Standard BioTools Appoints Alex Kim as Chief Financial Officer

    SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. ("Standard BioTools" or the "Company") (NASDAQ:LAB) today announced the appointment of Alex Kim as Chief Financial Officer, effective November 11, 2024. Kim, a co-founder and most recently Chief Operating Officer of Standard BioTools, brings nearly 30 years of financial and operations experience in the healthcare and life sciences industries to the role and will oversee Standard BioTools' finance organization. Michael Egholm, President and Chief Executive Officer of Standard BioTools, said, "I am thrilled to announce Alex as our next CFO. Having co-founded Standard BioTools with me, Alex's deep understan

    11/7/24 8:00:00 AM ET
    $LAB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the appointment of Charles ("Chuck") Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During Mr. Kummeth's tenure at Bio-Techne, he oversaw tremendous growth across all aspects of the business including annual revenue growth from $300M to over $1.1B, growth in the employee base from 800 to over 3,000, and the successful execution of 19 acquisitions, all while maintaining a 35% or better EBITDA level. Under Mr. Ku

    5/30/24 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321183506/en/Paula Dowdy (Photo: Business Wire) Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a world leading lab automation tools company based in the UK and is an advisor at EQT Life Sciences, one of Europe's leading investors targeting innovative

    3/21/24 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials